Back

The impact of primary percutaneous coronary intervention volume on prognosis of patients with ST elevation myocardial infarction

13 April 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 3 - Coronary Artery Disease Coronary Artery Disease, Other EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Professor Hamlet Hayrapetyan

Erebouni Medical Center, Yerevan (Armenia)

35 More presentations in this session

Presentation thumbnail
Doctor M. Sladojevic (Novi Sad, RS)
Abstract
Presentation thumbnail
Doctor G. Sulo (Bergen, NO)
Abstract
Presentation thumbnail
Doctor K. Villelabeitia (Madrid, ES)
Abstract
Presentation thumbnail
Professor K. Kaminski (Bialystok, PL)
Abstract
Presentation thumbnail
Doctor H. Seyfert (Demmin, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 3 - Coronary Artery Disease

The Event

Event poster

EuroPrevent 2019

13 April 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Primary percutaneous coronary intervention in a regional centre: pandemic impact
21 March 2026
thumbnail
Congress Presentation
Prognostic value of echocardiographic parameters in predicting major adverse cardiac events one year following st-segment elevation myocardial infarction
30 August 2024
thumbnail
Congress Presentation
Complete versus culprit-vessel only revascularization for patients with acute coronary syndromes and multivessel disease
2 September 2019
thumbnail
Congress Presentation
Efficacy and safety of upstream unfractionated heparin compared with downstream administration in ST-elevation myocardial infarction patients undergoing percutaneous coronary intervention.
8 March 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources